Parkinson's Treatment and DBS Surgery in India for Congolese Patients: What It Costs, and How to Decide Well

Author:- Dr. Dheeraj Bojwani Date Created:- 03-08-2026

Parkinson's disease rarely announces itself all at once — it is usually years of gradually worsening tremor, stiffness, and slowness, met with medication that works well at first and less well over time. In 24 years of advising patients through this exact progression, I have found that most Congolese families reach the point where medication alone is no longer enough long before anyone mentions that another option exists. This guide sets out plainly what deep brain stimulation is, what it costs in India against the Western alternatives some families consider, and the honest reality of accessing it from the DRC. For many families, simply knowing this treatment exists is the first real step, since it rarely comes up in routine local care.

Healing Journeys of Congolese Patients

Congolese Patients Share Their Experience

Key Takeaways

• The guide explains that deep brain stimulation (DBS) is not a cure for Parkinson’s disease, but it can significantly reduce motor symptoms such as tremor, stiffness and slowness in carefully selected patients whose medication is no longer providing adequate control. DBS involves implanting electrodes into specific brain regions connected to a pulse generator placed under the skin near the collarbone.
• The page 2 graphic highlights the major DBS access gap in Africa: only 5 of 54 African Union member states have documented DBS programmes, all in North or Southern Africa, with none in Central Africa. The guide explains that DBS requires a specialised ecosystem involving stereotactic neurosurgery, intraoperative neurophysiological monitoring and ongoing programming expertise.
• The guide stresses that DBS is not appropriate for every Parkinson’s patient. Candidates generally have motor symptoms that still respond to levodopa but experience significant fluctuations or dyskinesias. A levodopa response test and neuropsychological assessment are important before surgery is considered, while significant cognitive decline, psychiatric instability or certain forms of atypical parkinsonism may make DBS unsuitable.
• The page 2 outcome chart presents an illustrative pattern from DBS outcome studies: motor symptom control is shown at 45% with medication alone versus 75% with DBS plus adjusted medication, while time with good symptom control is shown at 55% versus 85%. The guide clearly notes that these are commonly reported patterns for well-selected advanced-stage patients and that individual results vary.
• The page 3 timeline shows why DBS requires an extended stay rather than a single surgical visit. Evaluation and neuropsychological assessment occur first, followed by MRI/CT and surgical planning, implantation, initial recovery and programming. The illustrated pathway extends to approximately 28 days, with follow-up programming continuing over subsequent weeks. The page 3 cost chart gives an indicative India range of US$18,000–30,000, compared with US$28,000–42,000 in France/Belgium, US$32,000–77,000 in the UK private sector and US$60,000–90,000 in the US.
• For Congolese patients, the guide recommends confirming genuine DBS candidacy before travelling, sending medication and symptom history rather than relying on imaging alone, clarifying whether the device is rechargeable or non-rechargeable, confirming the number of included programming sessions and budgeting with a 15–20% financial buffer. It also recommends starting the medical and attendant visa process early, maintaining current yellow-fever documentation and arranging long-term programming support in the DRC or planning future visits to India.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

Parkinson’s Disease Treatment and Deep Brain Stimulation

Patients

Congolese Patients

Key Specialists

Movement Disorder Neurologist and Functional Neurosurgeon

Treatment Purpose

Control disabling motor symptoms in selected advanced Parkinson’s patients

DBS Status

Does not cure Parkinson’s or stop disease progression

African Access

5 of 54 African Union states have documented DBS programmes

Central Africa

No documented DBS programme

Candidate Profile

Levodopa-responsive motor fluctuations or dyskinesias

Assessment

Levodopa response test and neuropsychological evaluation

India Cost

US$18,000–30,000

Device Check

Rechargeable versus non-rechargeable

Programming

Multiple sessions required after implantation

Typical Stay

Several weeks rather than a short surgical visit

Financial Buffer

15–20% above initial estimate

Visa

Paper medical visa and attendant visa

Entry Requirement

Current yellow-fever certificate

Follow-Up

Long-term programming support in the DRC or planned return visits to India

Key Warning

Do not proceed with DBS without formal candidacy assessment

Decision Principle

Confirm suitability first, then choose a high-volume DBS team capable of surgery, programming and long-term follow-up.

In Brief

For Congolese patients with advanced Parkinson’s disease, the guide recommends thorough candidacy assessment before considering DBS, including levodopa response and neuropsychological evaluation. Because DBS requires surgery followed by repeated programming and long-term device management, patients should confirm the device type, programming plan, total cost, length of stay and arrangements for future programming before travelling to India.

What Deep Brain Stimulation Actually Is

Deep brain stimulation, or DBS, involves implanting thin electrodes into specific, carefully targeted areas deep inside the brain, connected to a small pulse generator placed under the skin near the collarbone, similar in concept to a pacemaker. The device delivers continuous, mild electrical stimulation that helps regulate the abnormal brain activity behind Parkinson's motor symptoms — tremor, stiffness, and slowness — often significantly reducing them in patients who no longer respond well enough to medication alone. DBS does not cure Parkinson's disease and does not stop it progressing, but for the right patient, it can restore meaningful function and independence for years.

The Reality of DBS Access in Africa

This is where the picture becomes stark for a Congolese patient. Published research on DBS access across the African continent found established programmes in only three countries — Egypt, Morocco, and South Africa — with occasional availability in Algeria and Tunisia. Outside these five, DBS is not currently offered anywhere on the continent, including nowhere in Central Africa.

This gap exists even though Parkinson's disease itself is not rare in the DRC or the wider region — the barrier is not the disease's prevalence, but the extraordinarily specialised infrastructure DBS requires, which very few health systems in Africa have been able to build.

The one fact worth remembering

Who DBS Actually Helps

DBS is not right for every Parkinson's patient. It is generally considered for people whose motor symptoms still respond to levodopa medication but who experience significant fluctuations — good periods and bad periods within the same day — or dyskinesias, the involuntary movements that can accompany long-term medication use. A thorough evaluation, including a levodopa response test and neuropsychological assessment, determines candidacy before surgery is ever discussed as a real option. Patients with certain forms of atypical parkinsonism, significant cognitive decline, or psychiatric instability are generally not good candidates, regardless of how disabling their motor symptoms have become.

Why DBS Takes Weeks, Not a Single Day

Unlike a single operation with a defined recovery period, DBS unfolds in stages: evaluation, surgical planning, implantation, and then a series of programming visits over the following weeks to fine-tune the stimulation settings for each patient's specific symptoms.

What DBS Costs: DRC Reality vs India vs the West

Cost includes the device itself, the surgery, and initial programming, and this represents a real share of the total price given the specialised hardware involved.

In India, DBS surgery typically costs US$18,000 to US$30,000, depending on the specific device chosen (rechargeable devices generally cost more than non-rechargeable ones). In France or Belgium, private-sector costs typically run US$28,000 to US$42,000. In the UK's private sector, costs range roughly US$32,000 to US$77,000. In the US, the same procedure commonly costs US$60,000 to US$90,000. India's typical price sits at roughly a quarter to a third of the uninsured US figure.

What the number on the quote does not always show

A written estimate should specify exactly which device is included, whether it is rechargeable or non-rechargeable (rechargeable devices need fewer replacement surgeries over a patient's lifetime but cost more upfront), and how many programming sessions are included in the price. In 24 years of reviewing these quotes, I have found disputes almost never concern the headline figure — they concern what it silently left out. Get every line item in writing, and never pay the full balance before surgery.

What a Congolese Patient Should Weigh, Specifically

1. Confirm you are a genuine DBS candidate first — a proper evaluation, including a levodopa response test, should happen before surgery is discussed as a real plan.
2. Send your medication and symptom history, not just a scan, since candidacy depends heavily on how you respond to levodopa, not imaging alone.
3. Ask how many programming visits are included, and what happens if more are needed after you return home.
4. Budget in US dollars, with margin. The Congolese franc has weakened considerably against the dollar (roughly CDF 2,300–2,350 per US$1 in mid-2026, and it moves); build in a 15–20% buffer above the initial estimate.
5. Start the visa process early. DRC passport holders need a paper medical visa through the Embassy of India in Kinshasa (Avenue Batetela, Gombe), typically around two weeks once the hospital's invitation letter is ready; apply for an attendant visa at the same time.
6. Confirm your yellow fever certificate is current — mandatory for entry into India, at least 10 days before travel.
7. Plan for an extended stay, not a quick visit — the staged nature of DBS means several weeks in India is typical, not days.
8. Arrange long-term programming support back home — identify, before you travel, whether any DRC or regional facility can adjust your device settings periodically, or whether return visits to India will be needed.

Four signals that should make you pause

• DBS proposed without a proper candidacy evaluation, including a levodopa response test.
• No clear explanation of which device is included and why.
• No defined programming schedule, either during your stay or for long-term follow-up.
• Pressure to pay the full balance before a written surgical plan exists.

Why India Specifically for Parkinson's Treatment and DBS Surgery for Congolese Patients?

India operates some of the world's highest-volume DBS centres, with movement-disorder neurologists and functional neurosurgeons working together to assess candidacy honestly rather than defaulting every advanced Parkinson's patient toward surgery. Combined with English-language consultation throughout and hospital accreditation (NABH domestically, JCI internationally) that mirrors the standards used to evaluate hospitals in the US and Europe, India offers a combination of genuine expertise and lower cost that stands in stark contrast to the complete absence of this technology anywhere in Central Africa.

A closing word

Living with advanced Parkinson's disease is exhausting in ways that are hard to convey to anyone who has not experienced the daily unpredictability of "on" and "off" periods. DBS will not be right for every patient, but for the right candidate, it can offer years of restored function. What matters most is an honest, thorough evaluation before any decision is made. If you are able to share your medication history and recent evaluations, I am glad to give a direct, honest view on whether DBS is a path worth exploring for your specific situation.

Sources

• 🌐 National Medical Commission of India — verify any surgeon's registration · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) · nabh.co
• 🌐 Embassy of India, Kinshasa — medical visa requirements · eoikinshasa.gov.in
• 🌐 "Deep brain stimulation for movement disorders treatment in Africa," Parkinsonism & Related Disorders (2020) · sciencedirect.com/science/article/abs/pii/S0303846723005292
• 🌐 "A systematic review of health disparities research in DBS surgery for Parkinson's disease" · pmc.ncbi.nlm.nih.gov/articles/PMC10641459
• 🌐 World Health Organization — yellow fever vaccination requirements · who.int/health-topics/yellow-fever

Frequently Asked Questions by Congolese Patients about Parkinson's Treatment and DBS Surgery in India

What is deep brain stimulation?

DBS involves implanting thin electrodes into specific areas of the brain, connected to a pulse generator under the skin near the collarbone. The device delivers continuous electrical stimulation to help regulate abnormal brain activity.

Does DBS cure Parkinson’s disease?

No. The guide explains that DBS does not cure Parkinson’s or stop its progression, but it can provide meaningful improvement in motor symptoms for appropriately selected patients.

Who may be a candidate for DBS?

DBS is generally considered for patients whose symptoms still respond to levodopa but who experience significant motor fluctuations or dyskinesias. Formal evaluation is required before surgery.

What tests are needed before DBS?

The guide recommends a levodopa response test and neuropsychological assessment, along with the broader neurological and surgical evaluation needed to determine suitability.

Is DBS available in the DRC?

The guide states that there is no documented DBS programme anywhere in Central Africa, meaning Congolese patients requiring DBS need to seek treatment abroad.

How much does DBS cost in India?

The guide gives an indicative range of US$18,000–30,000, including the device, implantation and initial programming. The exact amount depends partly on the device selected.

What is the difference between rechargeable and non-rechargeable DBS devices?

The guide explains that rechargeable devices generally cost more initially but require fewer replacement surgeries over a patient's lifetime, while non-rechargeable devices have a lower upfront cost.

How long should Congolese patients stay in India?

DBS is a staged process spanning several weeks, including evaluation, surgical planning, implantation, recovery and programming. The illustrated page 3 pathway extends to approximately 28 days.

What should I check in the DBS quotation?

Confirm which device is included, whether it is rechargeable, how many programming sessions are covered and what happens if additional programming is required after returning to the DRC.

How should DBS programming be managed after returning home?

Before travelling, identify whether a DRC or regional facility can adjust the device settings periodically. If local programming is unavailable, the guide recommends planning for future return visits to India.

Page Summary

This guide helps Congolese patients understand Parkinson’s treatment and DBS surgery in India, particularly why DBS is considered only for carefully selected patients and why treatment involves weeks of evaluation, surgery and programming rather than a single operation. The page 2 graphic highlights the absence of documented DBS programmes in Central Africa, while the page 3 timeline and cost chart illustrate the staged treatment pathway and India's indicative US$18,000–30,000 cost. Device selection, programming support and long-term follow-up are central to the decision.

Citation Block

Field	Information
Topic	Parkinson’s Treatment and DBS Surgery in India for Congolese Patients
Treatment	Deep Brain Stimulation
Patients	Congolese Patients
Key Specialists	Movement Disorder Neurologist / Functional Neurosurgeon
Purpose	Motor symptom control in selected advanced Parkinson’s disease
Disease Effect	DBS does not cure Parkinson’s or stop progression
African Access	5 of 54 African Union states have documented DBS programmes
Central Africa	No documented DBS programme
Candidate Profile	Levodopa-responsive fluctuations or dyskinesias
Candidacy Assessment	Levodopa response test and neuropsychological evaluation
India Cost	US$18,000–30,000
Device Selection	Rechargeable versus non-rechargeable
Treatment Process	Evaluation, planning, implantation, recovery and programming
Programming	Multiple sessions over subsequent weeks
Stay	Several weeks rather than a short visit
Cost Transparency	Device, implantation, initial programming and additional programming
Financial Planning	15–20% buffer above initial estimate
Visa	Medical visa and attendant visa
Entry Requirement	Yellow-fever certificate
Follow-Up	Long-term programming support in the DRC or return visits to India
Warning Signs	No candidacy evaluation, unclear device, undefined programming schedule or advance-payment pressure
Key Decision	Confirm candidacy and long-term programming access before choosing surgery